, Tracking Stock Market Picks
Enter Symbol:
Paradigm System Solu (PSYS) [hlAlert]

up 74,925.00 %

Psychiatric Solutions, Inc. (PSYS) downgraded to Underweight with price target $30 by Piper Jaffray

Posted on: Wednesday,  Mar 31, 2010  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Underweight Paradigm System Solu (OTCBB: PSYS) on 03/31/2010, when the stock price was $30.01. Since
then, Paradigm System Solu has lost 99.87% as of 06/18/2014's recent price of $0.04.
If you would have followed this Piper Jaffray's recommendation on PSYS, you would have gained 74925% of your investment in 1540 days.

Psychiatric Solutions, Inc. (Psychiatric Solutions) is a provider of inpatient behavioral healthcare services in the United States. The Company operates 95 inpatient behavioral healthcare facilities with approximately 10,000 beds in 31 states, Puerto Rico, and the United States Virgin Islands. Through its inpatient behavioral healthcare facilities, Psychiatric Solutions offers a range of inpatient behavioral healthcare services for children, adolescents and adults. It offers these services through a combination of acute inpatient behavioral facilities and residential treatment centers (RTCs). Other behavioral healthcare services consist of its contract management business. The Company?s inpatient behavioral healthcare facilities division and other behavioural healthcare services accounted for 90% and 10%, respectively of its revenue during the year ended December 31, 2008. In November 2009, the Company completed the sale of its employee assistance program (EAP) business to Aetna, Inc.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy